Phase 2 Trial of Chemotherapy followed by Response-Based Whole Ventricular & Spinal Canal Irradiation (WVSCI) for Patients with Localized Non-Germinomatous Central Nervous System Germ Cell Tumor
Objective1.1.1 To monitor outcome to ensure that children and young adults with localized central nervous system (CNS) non-germinomatous germ cell tumors (NGGCT) treated with Induction chemotherapy followed by response evaluation and whole ventricular + spinal canal irradiation (WVSCI) will maintain the excellent 2-year progression free survival (PFS) rate as compared to ACNS0122. 1.1.2 To improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and receive WVSCI as compared to whole ventricular radiation on ACNS1123.
Protocol #ACNS2021
Trial Phase:Phase II
Principal Investigator:Park, Christopher
- Brain and Nervous System
- Virginia Commonwealth University
Get more detailed information at ClinicalTrials.gov
- Protocol Type Treatment
-
Research Study Team
Lindsey Gwaltney, MS, RN
Phone: +1 804-628-2112
Email Study Contact
Click "I'm Interested" to get started. If you have questions, call our study contact.
I'm InterestedHave a question? We're here to help.
Email us or call us with your request.
Send an Email ยป (804) 628-6430